FDA issues urgent recall across multiple states
Digest more
Ionis, FDA
Digest more
System integrates glucose biosensor with an AI-driven platform to show how food, activity, stress, sleep affect the body in real time
The FDA classifies this recall as Class II, which the agency describes as a situation "in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."
FDA recalls 7Up Zero Sugar Tropical Soda for being mislabeled full-sugar soda. The affected cans were sold in 12-packs in Alabama, Florida and Georgia. This was just classified as a Class II recall, meaning it may cause reversible health effects.
Shaman Botanicals has issued a formal response to the FDA’s recent warning letter on its 7-hydroxymitragynine (7-OH) products, backed by reports from leading researchers at Johns Hopkins, Harvard, UCLA,
Despite boasting a new owner, the Indiana manufacturing plant that Novo Nordisk picked up as part of its parent company's Catalent buyout last year continues to catch flak from the FDA. | Despite boasting a new owner,
The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new option for maintaining a healthy weight. The system uses a continuous glucose monitor,
In light of this, dermatologist Adam Friedman of the George Washington University has shared with Newsweek how you can choose safe and effective protection.
With skin cancer cases up 77% since 1994, the bipartisan legislation seeks to address regulatory hurdles that have blocked new sunscreen ingredients for decades.
The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it has in the past.